Literature DB >> 23183653

Case Study: A Novel Bacterial Contamination in Cell Culture Production--Leptospira licerasiae.

Joseph Chen1, Jesse Bergevin, Robert Kiss, Gordon Walker, Todd Battistoni, Patricia Lufburrow, Harry Lam, Anders Vinther.   

Abstract

Leptospira licerasiae, a novel bacterial contaminant found in Genentech cell culture manufacturing operations, poses a challenge to current microbial control strategies in upstream cell culture processes, as this microorganism is fully capable of passing through 0.1 μm sterilizing-grade filtration and is not detectable by standard microbiological methods described in major pharmaceutical compendia for microbial screening and quantification required for release of raw materials, in-process intermediates, and finished products in biopharmaceutical production. The root cause investigation was greatly aided by the genetic identification of the contaminant and subsequent confirmation by cultural method and real-time polymerase chain reaction assay from the affected product batches. The purpose of this case study is to share knowledge on the novel contaminant, L. licerasiae, and potential routes of contamination in the cell culture manufacturing environment from a series of investigations involving root cause analysis, impact assessments, risk assessment, and global corrective and preventative action, as well as to provide guidance on the detection and prevention of Leptospira contamination with the intent to aid the industry to continually improve microbial control strategies for the benefit of patients. LAY ABSTRACT: Leptospira licerasiae, a novel bacterial contaminant found in cell culture manufacturing operations, poses a challenge to current microbial control strategies in upstream cell culture processes because this microorganism is capable of passing through 0.1 μm sterilizing-grade membrane filters and is not detectable by standard microbiological methods used in biopharmaceutical production. The root cause investigation was greatly aided by the genetic identification of the contaminant and subsequent confirmation by cultural method and real-time polymerase chain reaction assay from the affected product batches. The purpose of this case study is to share knowledge on the novel contaminant, L. licerasiae, and potential routes of contamination in the cell culture manufacturing environment from a series of investigations to provide the industry with guidance on the detection and prevention of Leptospira contamination.

Entities:  

Mesh:

Year:  2012        PMID: 23183653     DOI: 10.5731/pdajpst.2012.00892

Source DB:  PubMed          Journal:  PDA J Pharm Sci Technol        ISSN: 1079-7440


  5 in total

Review 1.  Advancement in bioprocess technology: parallels between microbial natural products and cell culture biologics.

Authors:  Arpan A Bandyopadhyay; Anurag Khetan; Li-Hong Malmberg; Weichang Zhou; Wei-Shou Hu
Journal:  J Ind Microbiol Biotechnol       Date:  2017-02-09       Impact factor: 3.346

2.  Evidence for grow-through penetration of 0.2-μm-pore-size filters by Serratia marcescens and Brevundimonas diminuta.

Authors:  Simran Kaushal; Brandi Gervais; Scott Lute; Ajiri Eroraha; Patrick Faustino; Kurt Brorson; David Hussong
Journal:  J Ind Microbiol Biotechnol       Date:  2013-02-06       Impact factor: 3.346

3.  Mycoplasma contamination affects cell characteristics and decreases the sensitivity of BV2 microglia to LPS stimulation.

Authors:  Nianhua Feng; Xiaoxi Huang; Yanjun Jia
Journal:  Cytotechnology       Date:  2019-04-03       Impact factor: 2.058

Review 4.  Evaluating ultraviolet sensitivity of adventitious agents in biopharmaceutical manufacturing.

Authors:  Sarah M Meunier; Michael R Sasges; Marc G Aucoin
Journal:  J Ind Microbiol Biotechnol       Date:  2017-03-10       Impact factor: 3.346

5.  Impact of Dissolved Oxygen during UV-Irradiation on the Chemical Composition and Function of CHO Cell Culture Media.

Authors:  Sarah M Meunier; Biljana Todorovic; Emma V Dare; Afroza Begum; Simon Guillemette; Andrew Wenger; Priyanka Saxena; J Larry Campbell; Michael Sasges; Marc G Aucoin
Journal:  PLoS One       Date:  2016-03-14       Impact factor: 3.240

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.